查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1878851

ELISA檢測市場－全球產業規模、佔有率、趨勢、機會和預測，依方法、應用、技術、最終用戶、地區和競爭格局分類，2020-2030年預測

ELISA Test Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Method, By Application, By Technology, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球酵素連結免疫吸附試驗（ELISA）市場規模為24.9億美元，預計2030年將以7.84%的複合年成長率成長至39.2億美元。酵素連結免疫吸附試驗（ELISA）是一種主要用於檢測和定量生物樣本中可溶性物質（如胜肽、蛋白質、抗體和荷爾蒙）的生化技術。全球ELISA市場的成長主要受傳染病和慢性病（包括愛滋病和各種癌症）日益普遍的推動，這些疾病需要準確及時的診斷工具。此外，診斷技術的不斷進步，提高了ELISA檢測的敏感度、特異性和自動化程度，也大大促進了市場成長。

市場概覽
預測期 2026-2030
2024年市場規模 24.9億美元
2030年市場規模 39.2億美元
2025-2030年複合年成長率 7.84%
成長最快的細分市場 夾心ELISA
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：客戶之聲

第5章：全球ELISA檢測市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依方法（直接ELISA、間接ELISA、夾心ELISA、競爭性ELISA）
    • 按應用領域（疫苗研發、免疫學、診斷學、毒理學、藥物監測和製藥業、移植、其他）
    • 依技術分類（化學發光、比色、螢光）
    • 按最終使用者（醫院、診斷中心、研究實驗室、其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美ELISA檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲ELISA檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區ELISA檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲ELISA檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲ELISA檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球ELISA檢測市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux India Private Limited
  • Enzo Biochem Inc.
  • BioLegend, Inc.
  • ELISA Technologies, Inc.
  • RayBiotech, Inc.
  • Eurofins Scientific (Ireland) Limited

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 7621

The Global ELISA Test Market, valued at USD 2.49 Billion in 2024, is projected to experience a CAGR of 7.84% to reach USD 3.92 Billion by 2030. The Enzyme-Linked Immunosorbent Assay (ELISA) is a biochemical technique primarily employed for detecting and quantifying soluble substances such as peptides, proteins, antibodies, and hormones in biological samples. The global ELISA test market's expansion is significantly driven by the escalating prevalence of infectious and chronic diseases, including conditions like HIV and various cancers, which necessitate accurate and timely diagnostic tools. Furthermore, continuous advancements in diagnostic technology, enhancing the sensitivity, specificity, and automation of ELISA assays, contribute substantially to market growth.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.49 Billion
Market Size 2030USD 3.92 Billion
CAGR 2025-20307.84%
Fastest Growing SegmentSandwich ELISA
Largest MarketNorth America

Key Market Drivers

The global ELISA Test Market is significantly shaped by the escalating prevalence of infectious and chronic diseases, driving a persistent need for accurate and timely diagnostic solutions. The burden of such conditions necessitates widespread testing, with ELISA assays playing a crucial role in disease surveillance and management. For instance, according to the World Health Organization, as of 30 April 2024, over 7.6 million dengue cases were reported globally in 2024, demonstrating the continuous demand for effective diagnostic tools to monitor and control infectious disease outbreaks. This growing disease landscape directly increases the volume of diagnostic procedures required, thereby expanding the market for ELISA tests globally.

Key Market Challenges

High initial investment costs for advanced ELISA equipment and reagents represent a significant challenging factor in the global ELISA test market. The substantial capital expenditure required for acquiring and maintaining sophisticated ELISA systems can limit the adoption of these diagnostic tools, particularly in healthcare settings with restricted budgets. This directly impedes market growth by creating a barrier to entry for smaller laboratories and those in developing regions. For instance, according to a 2024 Lab Manager Industry and Equipment Trends Survey, 55 percent of respondents cited investment in tools, equipment, and instruments as a top challenge, with 64 percent noting difficulty in securing budget approval for new technology. These financial constraints often force laboratories to extend the lifespan of older, less efficient equipment or forgo advanced automation, impacting their capacity for high-throughput testing and the adoption of newer, more sensitive ELISA assays.

Key Market Trends

Miniaturization and Point-of-Care ELISA Platforms are significantly transforming the global ELISA test market by expanding diagnostic accessibility and speeding up result delivery in various settings. This trend facilitates testing closer to patients, moving beyond traditional centralized laboratories and enabling more immediate clinical decisions. The American Association for Clinical Chemistry (AACC) notably underscored the growing importance of decentralized diagnostic solutions by featuring point-of-care as a key topic at its 2023 Annual Scientific Meeting, encompassing a range of cutting-edge diagnostic tests. This strategic shift responds to the demand for rapid, on-site diagnostics that improve patient management, particularly for conditions requiring frequent monitoring or swift intervention. Abbott, a leading diagnostics company, demonstrated advancements in its point-of-care portfolio, with its second-quarter 2024 results highlighting strong demand for rapid diagnostics used for respiratory diseases, often utilizing compact, near-patient platforms. These advancements are critical for the broader adoption of ELISA technologies in diverse healthcare environments.

Key Market Players

  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux India Private Limited
  • Enzo Biochem Inc.
  • BioLegend, Inc.
  • ELISA Technologies, Inc.
  • RayBiotech, Inc.
  • Eurofins Scientific (Ireland) Limited

Report Scope:

In this report, the Global ELISA Test Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

ELISA Test Market, By Method:

  • Direct ELISA
  • Indirect ELISA
  • Sandwich ELISA
  • Competitive ELISA

ELISA Test Market, By Application:

  • Vaccine Development
  • Immunology
  • Diagnostics
  • Toxicology
  • Drug Monitoring and Pharmaceutical Industry
  • Transplantation
  • Others

ELISA Test Market, By Technology:

  • Chemiluminescent
  • Colorimetric
  • Fluorescent

ELISA Test Market, By End User:

  • Hospitals
  • Diagnostic Centers
  • Research Laboratories
  • Others

ELISA Test Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global ELISA Test Market.

Available Customizations:

Global ELISA Test Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global ELISA Test Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Method (Direct ELISA, Indirect ELISA, Sandwich ELISA, Competitive ELISA)
    • 5.2.2. By Application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Monitoring and Pharmaceutical Industry, Transplantation, Others)
    • 5.2.3. By Technology (Chemiluminescent, Colorimetric, Fluorescent)
    • 5.2.4. By End User (Hospitals, Diagnostic Centers, Research Laboratories, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America ELISA Test Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Method
    • 6.2.2. By Application
    • 6.2.3. By Technology
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States ELISA Test Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Method
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Technology
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada ELISA Test Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Method
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Technology
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico ELISA Test Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Method
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Technology
        • 6.3.3.2.4. By End User

7. Europe ELISA Test Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Method
    • 7.2.2. By Application
    • 7.2.3. By Technology
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany ELISA Test Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Method
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Technology
        • 7.3.1.2.4. By End User
    • 7.3.2. France ELISA Test Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Method
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Technology
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom ELISA Test Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Method
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Technology
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy ELISA Test Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Method
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Technology
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain ELISA Test Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Method
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Technology
        • 7.3.5.2.4. By End User

8. Asia Pacific ELISA Test Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Method
    • 8.2.2. By Application
    • 8.2.3. By Technology
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China ELISA Test Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Method
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By End User
    • 8.3.2. India ELISA Test Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Method
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan ELISA Test Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Method
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea ELISA Test Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Method
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Technology
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia ELISA Test Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Method
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Technology
        • 8.3.5.2.4. By End User

9. Middle East & Africa ELISA Test Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Method
    • 9.2.2. By Application
    • 9.2.3. By Technology
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia ELISA Test Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Method
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE ELISA Test Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Method
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa ELISA Test Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Method
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By End User

10. South America ELISA Test Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Method
    • 10.2.2. By Application
    • 10.2.3. By Technology
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil ELISA Test Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Method
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia ELISA Test Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Method
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina ELISA Test Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Method
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Technology
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global ELISA Test Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. F. Hoffmann-La Roche Ltd.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Thermo Fisher Scientific, Inc.
  • 15.3. Becton, Dickinson and Company
  • 15.4. Bio-Rad Laboratories, Inc.
  • 15.5. bioMerieux India Private Limited
  • 15.6. Enzo Biochem Inc.
  • 15.7. BioLegend, Inc.
  • 15.8. ELISA Technologies, Inc.
  • 15.9. RayBiotech, Inc.
  • 15.10. Eurofins Scientific (Ireland) Limited

16. Strategic Recommendations

17. About Us & Disclaimer